全文获取类型
收费全文 | 40133篇 |
免费 | 3301篇 |
国内免费 | 166篇 |
专业分类
耳鼻咽喉 | 492篇 |
儿科学 | 1073篇 |
妇产科学 | 681篇 |
基础医学 | 4816篇 |
口腔科学 | 700篇 |
临床医学 | 4230篇 |
内科学 | 8698篇 |
皮肤病学 | 775篇 |
神经病学 | 3325篇 |
特种医学 | 1383篇 |
外国民族医学 | 2篇 |
外科学 | 6452篇 |
综合类 | 673篇 |
现状与发展 | 1篇 |
一般理论 | 30篇 |
预防医学 | 3400篇 |
眼科学 | 1166篇 |
药学 | 2751篇 |
中国医学 | 117篇 |
肿瘤学 | 2835篇 |
出版年
2023年 | 262篇 |
2022年 | 516篇 |
2021年 | 1265篇 |
2020年 | 709篇 |
2019年 | 962篇 |
2018年 | 1098篇 |
2017年 | 768篇 |
2016年 | 837篇 |
2015年 | 968篇 |
2014年 | 1271篇 |
2013年 | 1658篇 |
2012年 | 2520篇 |
2011年 | 2472篇 |
2010年 | 1466篇 |
2009年 | 1244篇 |
2008年 | 2175篇 |
2007年 | 2273篇 |
2006年 | 2159篇 |
2005年 | 2099篇 |
2004年 | 1937篇 |
2003年 | 1780篇 |
2002年 | 1694篇 |
2001年 | 876篇 |
2000年 | 790篇 |
1999年 | 741篇 |
1998年 | 420篇 |
1997年 | 352篇 |
1996年 | 347篇 |
1995年 | 287篇 |
1994年 | 251篇 |
1993年 | 232篇 |
1992年 | 417篇 |
1991年 | 331篇 |
1990年 | 386篇 |
1989年 | 311篇 |
1988年 | 321篇 |
1987年 | 297篇 |
1986年 | 271篇 |
1985年 | 256篇 |
1984年 | 268篇 |
1983年 | 252篇 |
1982年 | 244篇 |
1981年 | 222篇 |
1980年 | 233篇 |
1979年 | 228篇 |
1978年 | 176篇 |
1977年 | 148篇 |
1976年 | 154篇 |
1974年 | 161篇 |
1973年 | 137篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
2.
3.
Daniel Schar Pawin Padungtod Nguyen Tung Michael OLeary Wantanee Kalpravidh Filip Claes 《Influenza and other respiratory viruses》2019,13(6):618-621
Among the chief limitations in achieving early detection and control of animal‐origin influenza of pandemic potential in high‐risk livestock populations is the existing lag time between sample collection and diagnostic result. Advances in molecular diagnostics are permitting deployment of affordable, rapid, highly sensitive, and specific point‐of‐capture assays, providing opportunities for targeted surveillance driving containment strategies with potentially compelling returns on investment. Interrupting disease transmission at source holds promise of disrupting cycles of animal‐origin influenza incursion to endemicity and limiting impact on animal production, food security, and public health. Adoption of new point‐of‐capture diagnostics should be undertaken in the context of promoting robust veterinary services systems and parallel support for operationalizing pre‐authorized plans and communication strategies that will ensure that the full potential of these new platforms is realized. 相似文献
4.
5.
6.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
7.
8.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
9.
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease 下载免费PDF全文
10.
Quang Ngoc Nguyen Linh Dieu Vuong Van-Long Truong To Van Ta Nam Trung Nguyen Hung Phi Nguyen Ha Hoang Chu 《Pathology, research and practice》2019,215(5):885-892
Genetic and epigenetic alterations importantly contribute to the pathogenesis of lung cancer. In the study, we measured the frequency and distribution of molecular abnormalities of EGFR as well as the aberrant promoter methylations of BRCA1, MGMT, MLH1, and RASSF1A in Vietnamese lung adenocarcinomas. We investigated the association between genetic and epigenetic alteration, and between each abnormality with clinicopathologic parameters. Somatic EGFR mutation that was found in 49/139 (35.3%) lung adenocarcinomas showed a significant association with young age, female gender, and non-smokers. EGFR overexpression was identified in 82 tumors (59.0%) and statistical relationships with EGFR or BRCA1 methylation but not EGFR mutation. In addition, EGFR, BRCA1, MGMT, MLH1, and RASSF1A methylations were found in 33 (23.7%), 41 (29.5%), 46 (33.1%), 28 (20.1%), and 41 (29.5%) cases of a total of 139 lung adenocarcinomas, respectively. The RASSF1A methylation was found to be linked to the smoking habit. Methylations in MGMT and RASSF1A were also found to correlate with metastasis status. Furthermore, the distribution of EGFR mutation and that of BRCA1, MGMT or RASSF1A methylation were significantly exclusive in lung adenocarcinomas. The main finding of our study demonstrate that epigenetic abnormalities might play a critical role for the lung tumorigenesis in patients with smoking history and metastasis, and partly affect the predictive value of EGFR mutations through blocking expression due to promoter EGFR hypermethylation. Mutually exclusive distribution of genetic and epigenetic alterations reflects differently biological characteristics in the etiology of lung adenocarcinomas. 相似文献